OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Optimizing these processes involves fine-tuning various factors, including cell line selection, media composition, and bioreactor environments. A key goal is to maximize antibody titer while lowering production costs and